MedTrace Logo

Perception-Action Approach Intervention for Infants With Congenital Muscular Torticollis

NCT02907801 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2018-08-13

No results posted yet for this study

Summary

Infants with congenital muscular torticollis (CMT) display postural and functional asymmetry that interferes with their development. The use of the Perception-Action Approach (P-AA) intervention in infants with CMT is supported by a single case report and needs to be researched further to determine its efficacy. This study will investigate the immediate effects of the P-AA intervention on habitual head deviation from midline, active head rotation range of motion, and functional use of both sides of the body in infants with CMT.

The participants will be 3 infants with CMT, aged birth to 9 months. A randomized, nonconcurrent A-B multiple baseline design across subjects will be used. The intervention phase will include 5 daily PT sessions, with outcome data collected at the end of each session.

It is hypothesized that improvements on all outcome measures will be documented upon the initiation of the P-A Approach intervention, with the most substantial change expected in habitual head deviation from midline measured by still photography.

Conditions

  • Congenital Muscular Torticollis

Interventions

BEHAVIORAL

Perception-Action Approach

Environmental set-up, gentle manual guidance, and caregiver education

Sponsors & Collaborators

  • Ability Pediatric Physical Therapy, LLC

    collaborator OTHER

  • Rosalind Franklin University of Medicine and Science

    lead OTHER

Principal Investigators

  • Mary Rahlin, PT, DHS, PCS · Rosalind Franklin University of Medicine and Science

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
9 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-10
Primary Completion
2018-03-26
Completion
2018-03-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02907801 on ClinicalTrials.gov